The Scientist

» gene drive, immunology and disease/medicine

Most Recent

image: Contributors

Contributors

By | January 1, 2017

Meet some of the people featured in the January 2017 issue of The Scientist.

0 Comments

image: Gene Drives and Other Controversies

Gene Drives and Other Controversies

By | January 1, 2017

Aedes and Anopheles control; three-parent babies; the PhD glut

0 Comments

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

image: Using Gene Drives to Limit the Spread of Malaria

Using Gene Drives to Limit the Spread of Malaria

By | January 1, 2017

Introducing genetic changes into mosquito populations could be key to effective malaria control.

2 Comments

image: Infographic: Using Gene Drive to Control Malaria

Infographic: Using Gene Drive to Control Malaria

By | January 1, 2017

For years, researchers have looked to genetically modify mosquitoes to prevent the spread of malaria. Now they have a promising strategy.

0 Comments

image: UN Rejects Calls for Moratorium on Gene Drive Research

UN Rejects Calls for Moratorium on Gene Drive Research

By | December 23, 2016

Activists claim the technology is too risky, but scientists advise the United Nations to continue to support gene drive research.

0 Comments

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

image: Naive T Cells Find Homes in Lymphoid Tissue

Naive T Cells Find Homes in Lymphoid Tissue

By | December 2, 2016

The human lymph nodes and spleen maintain unique, compartmentalized sets of naive T cells well into old age.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Inflammation Drives Gut Bacteria Evolution
Business Birmingham